Newsroom
Sorted by: Latest
-
Little Rapids Corporation Unites Shawano Specialty Papers and Nexxa as Rapids Paper + Packaging
GREEN BAY, Wis.--(BUSINESS WIRE)--Shawano Specialty Papers and Nexxa unite as Rapids Paper + Packaging, advancing sustainable paper and packaging solutions....
-
Adobe to Announce Q1 FY2026 Earnings Results on March 12, 2026
SAN JOSE, Calif.--(BUSINESS WIRE)--Today, Adobe (Nasdaq:ADBE), the global technology leader that unleashes creativity, productivity and customer experiences through innovative tools and platforms, announced it will release its first quarter fiscal year 2026 results after the market closes on Thursday, March 12, 2026, followed by a conference call with investors from 2-3 p.m. Pacific Time. The conference call will be streamed live on the Adobe Investor Relations Site. Following the call, a recor...
-
Nassau Financial Group Continues to Expand Reimagine Insurtech Program
HARTFORD, Conn.--(BUSINESS WIRE)--Nassau Financial Group announced two investments in Insurtech startups made through its expanded Nassau Reimagine program....
-
SubArc Hercules™ System Increases Deposition Rates and Reduces Welding Time by an Average of Thirty Percent
APPLETON, Wis.--(BUSINESS WIRE)--Miller and Hobart Filler Metals announce the launch of the new SubArc Hercules™ system....
-
Searchlight Capital Partners Completes Sale of Euclid Transactional to CRC Group
NEW YORK--(BUSINESS WIRE)--Searchlight Capital Partners, L.P. (“Searchlight”), a leading global private investment firm, today announced the completion of the sale of Euclid Transactional, LLC (“Euclid Transactional” or the “Company”), a leading global provider of transactional insurance solutions specializing in representations and warranties, and tax liability insurance to CRC Group, a leading independent wholesale specialty and MGA business. Euclid Transactional is a premier underwriting pla...
-
AM Best Affirms Credit Ratings of Alleghany Corporation and Its Affiliates
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best affirmed the Financial Strength Rating (FSR) of A++ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “aa+” (Superior) of Transatlantic Reinsurance Company and its subsidiaries (collectively referred to as TransRe). In addition, AM Best has affirmed the Long-Term ICRs and the Long-Term Issue Credit Ratings (Long-Term IR) of “a+” (Excellent) of Alleghany Corporation (Alleghany) and Transatlantic Holdings, Inc. The outlook of these Credi...
-
Samson Rock Capital LLP UK Regulatory Announcement: Form 8.3 - Amendment
LONDON--(BUSINESS WIRE)-- FORM 8.3 AMENDMENT - THIS FORM REPLACES THE DISCLOSURE PUBLISHED 13:47 ON 27/02/26 AND THE DISCLOSURE PUBLISHED AT 11:04 ON 02/03/26. CHANGES HAVE BEEN MADE TO SECTION 2A. PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions d...
-
PHCbi推出LiCellGrow™細胞擴增系統,以支援高品質、高效率的細胞和基因療法生產
東京--(BUSINESS WIRE)--(美國商業資訊)-- 全球實驗室樣本儲存和細胞培養解決方案供應商、PHC Holdings Corporation(總部:東京都千代田區)旗下子公司PHC Corporation生物醫學事業部(總部:東京都千代田區;總裁:Nobuaki Nakamura;以下簡稱「PHCbi」)今日宣布,在日本和全球部分其他國家(*2)推出用於研究用途的全新細胞擴增系統LiCellGrow™(*1)。該系統使療法研發人員能夠即時視覺化細胞代謝變化,並自動控制培養條件,旨在提升新型先進療法生產的品質和效率。 PHCbi將於3月19日至20日在日本神戶國際會議中心和神戶國際展覽中心舉行的第25屆日本再生醫學學會大會上展出LiCellGrow™。 細胞和基因療法(CGT)利用細胞和遺傳物質開發個人化醫療方案,正迅速發展成為遺傳病和癌症等疑難病症極具前景的治療選擇。然而,在CGT產品生產中,細胞特性差異和生產複雜性是維持產品品質穩定的一大挑戰。這導致研發人員面臨生產效率不彰、產量下降和生產成本高於傳統療法的問題。為克服這些挑戰,療法研發人員必須能夠辨識CGT產品生產中...
-
PHCbi lança o sistema de expansão celular LiCellGrow™ para apoiar a produção eficiente e de alta qualidade de terapias celulares e genéticas
TÓQUIO--(BUSINESS WIRE)--A Divisão Biomédica da PHC Corporation (sede: Chiyoda-ku, Tóquio; Presidente: Nobuaki Nakamura; doravante “PHCbi”), fornecedora global de soluções para armazenamento de amostras laboratoriais e cultivo celular e subsidiária da PHC Holdings Corporation (Sede: Chiyoda-ku, Tóquio), anunciou hoje o lançamento de seu novo sistema de expansão celular LiCellGrow™(*1) para uso em pesquisa no Japão e em outros países selecionados globalmente(*2). O sistema foi projetado para mel...
-
PHCbi推出LiCellGrow™细胞扩增系统,以支持高质量、高效率的细胞和基因疗法生产
东京--(BUSINESS WIRE)--(美国商业资讯)-- 全球实验室样本存储和细胞培养解决方案提供商、PHC Holdings Corporation(总部:东京都千代田区)旗下子公司PHC Corporation生物医学事业部(总部:东京都千代田区;总裁:Nobuaki Nakamura;以下简称“PHCbi”)今日宣布,在日本和全球部分其他国家(*2)推出用于研究用途的全新细胞扩增系统LiCellGrow™(*1)。该系统使疗法研发人员能够实时可视化细胞代谢变化,并自动控制培养条件,旨在提升新型先进疗法生产的质量和效率。 PHCbi将于3月19日至20日在日本神户国际会议中心和神户国际展览中心举行的第25届日本再生医学学会大会上展出LiCellGrow™。 细胞和基因疗法(CGT)利用细胞和遗传物质开发个性化医疗方案,正迅速发展成为遗传病和癌症等疑难病症极具前景的治疗选择。然而,在CGT产品生产中,细胞特性差异和生产复杂性是维持产品质量稳定的一大挑战。这导致研发人员面临生产效率降低、产量下降和生产成本高于传统疗法的问题。为克服这些挑战,疗法研发人员必须能够识别CGT产品生产中...